Conquering Diseases

Study Of Ending Hormone Treatment After An Exceptional Response To Metastatic Prostate Cancer Hormone Treatment

Description

Seeking men whose metastatic prostate cancer has responded exceptionally well to therapy that included a medication to decrease testosterone and a medication to prevent growth signals in the body from male hormones including testosterone for a study of interrupting hormone treatment to allow testosterone levels to recover.

Overview

Participants in this study will stop taking hormonal medications. Every 12 weeks participants will be assessed. If there is any sign of the cancer growing back the hormone treatment would resume until your doctor feels like it is no longer benefitting you.

What we're hoping for

We are studying whether interrupting hormone therapy for men whose metastatic prostate cancer has responded exceptionally well to the treatment will allow testosterone levels to recover and improve their quality of life.

Additional Information

ClinicalTrials.gov Identifier: NCT05241860

 Principal Investigator

Kriti  Mittal, MD, MS

UMass Memorial Health

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989